Papers
6
Total Citations
76
H-Index
4
About
Lars Lund is a leading urological surgeon and researcher whose work spans erectile dysfunction, robotic surgery, and renal cancer treatment. His most cited study (32 citations) is a landmark prospective, placebo-controlled trial demonstrating that low-intensity extracorporeal shockwave therapy (LI-ESWT) can improve erectile dysfunction in men following radical prostatectomy—offering new hope for post-surgical penile rehabilitation. Lund has also made significant contributions to surgical education, showing in a 2019 study (21 citations) that prior video game experience provides a measurable advantage in high-fidelity virtual reality robotic surgery simulation, with implications for training the next generation of robotic surgeons. He is a founding member of the Nordic Renal Cancer Group (NORENCA), and his survey of renal tumor treatment across Nordic countries (9 citations) has helped harmonize clinical practices across 25 million people. Lund’s prospective work comparing robot-assisted partial nephrectomy to percutaneous cryoablation for renal cell carcinoma (4 citations) provides critical evidence on renal functional outcomes. His national database study on robotic versus laparoscopic urological surgery (4 citations) has informed safety benchmarks in Denmark. With a career focused on rigorous prospective trials and collaborative Nordic research, Lund is shaping evidence-based urological practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6